By showing a critical role for sialylation in the biophysical properties of mucus and mucus transport, the study identifies a possible therapeutic target for the treatment of cystic fibrosis and other ...

This binding increased a liquid layer vital for mucus clearance in cystic fibrosis cells by 50%, according to a study published Oct. 9 in Nature Chemistry.

Novel therapy could help people with asthma, COPD, cystic fibrosis and cancer-related lung disease Experimental drug reduces airway mucus that exacerbates common lung diseases Date: March 24, 2022 ...

Cystic fibrosis is a serious genetic disease that affects the lungs and other organs. It involves the mutation of a gene that affects mucous production. Instead of making mucus that’s thin and ...

Latest studies show Us pharma giant Vertex's new CF wonder pill Alyftrek has shown better results than their currently available drug Kaftrio.

It’s produced by special cells within the epithelium. This is a tissue that lines the organs, cavities and surfaces in your ...

Cystic fibrosis is a hereditary disease that so far has been incurable. Those affected have thick, viscous mucus secretions in their lungs, and lung function diminishes steadily over time.

A UB-led research team has developed molecules that could help unclog thick, sticky mucus from the lungs of people suffering from cystic fibrosis. The chronic disease is caused by a defective protein ...

BUFFALO, N.Y. — A University at Buffalo-led research team has developed molecules that could help unclog thick, sticky mucus from the lungs of people suffering from cystic fibrosis. The chronic ...

Synthetic molecules can ‘ferry’ mucus-clearing ions blocked by cystic fibrosis Developed by UB researchers, synthetic anion binders could one day help treat chronic lung disease ...